SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Satchel Paige Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientSatchel Paige
Date of birth1906-07-07
IdentifiersMRN HR-ML047-SYN-TD; SSN (made up) 000-47-3381
Document date2026-11-01
AuthorDelphine Whitaker-Osei, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing primary care for two years of breathlessness on exertion and a morning cough: history, examination, blood tests including alpha-1 antitrypsin and eosinophils, ECG, NT-proBNP, cardiovascular risk, vaccines, a reliever inhaler and a pulmonology consultation. Concerns: Breathless on stairs and on walks he used to take easily; He wants straight answers and his own numbers, and to be treated the same as anyone else; He wants to keep fishing and speaking to young people. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Albuterol 90 micrograms per inhalation metered-dose inhaler with a spacer, two inhalations every four hours as needed for breathlessnessTwo inhalations with a spacer every 4 hours as neededRespiratory tract route1979-07-14activeS
Umeclidinium 62.5 micrograms with vilanterol 25 micrograms dry powder inhaler (a LAMA with a LABA), one inhalation once a dayOne inhalation each morning; a strong, deep breath inRespiratory tract route1979-07-28activeS
Atorvastatin 20 mg tablet once a dayOne tablet each eveningOral route1979-07-14activeS
Prednisone 40 mg (two 20 mg tablets) by mouth each morning for five daysTwo tablets each morning with food for five daysOral route1979-09-22 to 1979-09-26completedS
Doxycycline 100 mg capsule by mouth twice a day for five daysOne capsule twice a day with a full glass of water, sitting up, for five daysOral route1979-09-22 to 1979-09-26completedS

Procedures

ProcedureDatesStatusEvidence
12-lead ECG: sinus rhythm at 82; normal axis; no Q waves, ST changes or signs of right ventricular strain; P waves normal1979-07-14 to 1979-07-14completedS
Spirometry before and after 400 micrograms of albuterol, meeting ATS/ERS acceptability and repeatability standards, interpreted with the GLI Global race-neutral reference equations: post-bronchodilator FEV1 2.02 L (61% predicted), FVC 3.48 L, FEV1/FVC 0.58; a 0.10 L (5%) bronchodilator response1979-07-28 to 1979-07-28completedS
Low-dose CT of the chest for lung cancer screening: centrilobular emphysema, worst in the upper lobes; a 4 mm solid nodule in the right lower lobe (Lung-RADS 2, benign appearance); moderate coronary artery calcification; no mass or enlarged nodes1979-08-04 to 1979-08-04completedS
Outpatient pulmonary rehabilitation, twice a week for ten weeks (20 sessions): endurance and strength training, breathing techniques and education1979-08-11 to 1979-10-22completedS
Chest X-ray, posteroanterior and lateral: hyperinflated lungs with flattened diaphragms; no consolidation, effusion, pneumothorax or enlarged heart1979-09-22 to 1979-09-22completedS
Advance care planning conversation, about 25 minutes, with his consent1979-10-06 to 1979-10-06completedS
Ultrasound of the abdominal aorta for aneurysm screening: maximum diameter 2.4 cm; no aneurysm1979-10-20 to 1979-10-20completedS
12-lead ECG after the exacerbation: sinus rhythm at 76; unchanged from intake; no ischemic changes, arrhythmia or right heart strain1979-10-27 to 1979-10-27completedS

Immunizations

DateVaccineStatusEvidence
1979-07-14Pneumococcal conjugate vaccine PCV20, single dosecompletedS
1979-07-14Tdap, boostercompletedS
1979-10-06Influenza vaccine, high-dose, this seasoncompletedS
1979-10-06Respiratory syncytial virus vaccine, single dosecompletedS
1979-10-06COVID-19 mRNA vaccine, this season's formulacompletedS
1979-10-06Recombinant zoster vaccine, dose 1 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1938Arm trouble from the late 1930s, with an arm injury in 1938; recovered the next yearD (CLM-0005)
In his later years (date not recorded)Emphysema and heart trouble in his later years; onset, diagnosis and treatment not recordedD (CLM-0009)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
Breathless on stairs and on walks he used to take easilyactiveS
He wants straight answers and his own numbers, and to be treated the same as anyone elseactiveS
He wants to keep fishing and speaking to young peopleactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 15.2 on 1979-07-14; Leukocytes [#/volume] in Blood by Automated count 7.1 on 1979-07-14; Eosinophils [#/volume] in Blood by Automated count 0.08 on 1979-07-14; Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma 142 on 1979-07-14; Sodium [Moles/volume] in Serum or Plasma 140 on 1979-07-14; Potassium [Moles/volume] in Serum or Plasma 4.3 on 1979-07-14; Creatinine [Mass/volume] in Serum or Plasma 1.08 on 1979-07-14; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1974)/1.73 sq M 71 on 1979-07-14; Glucose [Mass/volume] in Serum or Plasma 96 on 1979-07-14; Hemoglobin A1c/Hemoglobin.total in Blood 5.6 on 1979-07-14; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 21 on 1979-07-14; Cholesterol [Mass/volume] in Serum or Plasma 158 on 1979-09-08; Cholesterol in HDL [Mass/volume] in Serum or Plasma 46 on 1979-09-08; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 86 on 1979-09-08; Triglyceride [Mass/volume] in Serum or Plasma 130 on 1979-09-08; Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 92 on 1979-07-14; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 1979-10-27; Total score [AUDIT-C] 1 on 1979-07-14; FEV1 --pre bronchodilation 1.92 on 1979-07-28; FEV1 --post bronchodilation 2.02 on 1979-07-28; Forced vital capacity [Volume] Respiratory system --post bronchodilation 3.48 on 1979-07-28; FEV1/FVC --post bronchodilation 0.58 on 1979-07-28; FEV1 measured/predicted 61 on 1979-07-28; pH of Arterial blood 7.42 on 1979-07-28; Carbon dioxide [Partial pressure] in Arterial blood 40 on 1979-07-28; Oxygen [Partial pressure] in Arterial blood 70 on 1979-07-28; Six minute walk test 425 on 1979-10-27; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1979-10-06; Total score [Mini-Cog] 5 on 1979-10-06 [S]

Strengths and supports: engagement in care [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Breathlessness on exertion for about two years, now after one flight of stairs or a block on the level (mMRC 2), with a morning cough and a little clear sputum most days; no chest pain, ankle swelling, orthopnea, wheeze at rest or weight loss; a former smoker of about 30 pack-years; cause under evaluation with spirometry and a pulmonology consultationresolvedconfirmed R06.09S — Synthetic presenting problem anchored to his documented emphysema; superseded when spirometry at the consultation confirmed COPD.
Chronic obstructive pulmonary disease, GOLD grade 2 (post-bronchodilator FEV1/FVC 0.58, FEV1 61% predicted by the race-neutral GLI Global equations), GOLD group B (CAT 18, mMRC 2, no exacerbation in the past year); alpha-1 antitrypsin normal; blood eosinophils 0.08 x 10^3/uL; synthetic modern diagnosis linked to his documented emphysemaactiveconfirmed J44.9S — Synthetic modern diagnosis made at the consultation, anchored to his documented emphysema; its onset and course in the modern episode are synthetic.
Former cigarette smoker, about 30 pack-years, stopped eleven years ago on his own; no use sinceactiveconfirmed Z87.891S — Synthetic smoking history: whether he smoked is not documented in the sources read, so the history is synthetic and labeled as such.
Hyperlipidemia: LDL 148 mg/dL, HDL 44 and triglycerides 160 at intake; estimated 10-year cardiovascular risk about 18 percent; atorvastatin started by shared decisionactiveconfirmed E78.5S — Synthetic cardiovascular risk factor anchored to his documented heart trouble; not a claim about his real lipids.
Moderate exacerbation of COPD with a viral cold: more breathlessness, more sputum turning green, and wheeze for three days; oxygen saturation 92 percent; no pneumonia on chest X-ray; treated at home with prednisone and doxycycline; recoveredresolvedconfirmed J44.1S — Synthetic exacerbation at the sick visit; not a historical claim.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1979-07-14Hemoglobin [Mass/volume] in Blood15.2g/dL13.2-17.1 g/dLNormalS
1979-07-14Leukocytes [#/volume] in Blood by Automated count7.110*3/uL3.8-10.8 10*3/uLNormalS
1979-07-14Eosinophils [#/volume] in Blood by Automated count0.0810*3/uLFor COPD treatment decisions: below 0.10 argues against an inhaled corticosteroid; 0.30 or more favors oneNormalS
1979-07-14Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma142mg/dL90-200 mg/dLNormalS
1979-07-14Sodium [Moles/volume] in Serum or Plasma140mmol/L135-146 mmol/LNormalS
1979-07-14Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.3 mmol/LNormalS
1979-07-14Creatinine [Mass/volume] in Serum or Plasma1.08mg/dL0.7-1.3 mg/dLNormalS
1979-07-14Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1974)/1.73 sq M71mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1979-07-14Glucose [Mass/volume] in Serum or Plasma96mg/dL65-99 mg/dLNormalS
1979-07-14Hemoglobin A1c/Hemoglobin.total in Blood5.6%<=5.6%NormalS
1979-07-14Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma21U/L9-46 U/LNormalS
1979-07-14Cholesterol [Mass/volume] in Serum or Plasma224mg/dL<=199 mg/dLHighS
1979-07-14Cholesterol in HDL [Mass/volume] in Serum or Plasma44mg/dL>=40 mg/dLNormalS
1979-07-14Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation148mg/dL<=99 mg/dLHighS
1979-07-14Triglyceride [Mass/volume] in Serum or Plasma160mg/dL<=149 mg/dLHighS
1979-07-14Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma92pg/mLBelow 125 pg/mL makes heart failure unlikely in an outpatientNormalS
1979-07-14Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
1979-07-14Total score [AUDIT-C]1{score}S
1979-07-28FEV1 --pre bronchodilation1.92LLower limit of normal, GLI Global (race-neutral) for age, sex and heightLowS
1979-07-28FEV1 --post bronchodilation2.02LLower limit of normal, GLI Global (race-neutral)LowS
1979-07-28Forced vital capacity [Volume] Respiratory system --post bronchodilation3.48LLower limit of normal, GLI Global (race-neutral)NormalS
1979-07-28FEV1/FVC --post bronchodilation0.58{ratio}GOLD fixed ratio 0.70; post-bronchodilator ratio below 0.70 confirms airflow obstruction (GLI Global lower limit of normal about 0.62)LowS
1979-07-28FEV1 measured/predicted61%GOLD grade 1 at 80% or more, grade 2 at 50 to 79%LowS
1979-07-28pH of Arterial blood7.42[pH]7.35-7.45 [pH]NormalS
1979-07-28Carbon dioxide [Partial pressure] in Arterial blood40mm[Hg]35-45 mmHgNormalS
1979-07-28Oxygen [Partial pressure] in Arterial blood70mm[Hg]Long-term oxygen threshold: 55 mm Hg or less (60 or less with cor pulmonale or polycythemia)LowS
1979-07-28Six minute walk test360mPredicted about 520 m for his age, sex and height; lower limit about 400 mLowS
1979-09-08Cholesterol [Mass/volume] in Serum or Plasma158mg/dL<=199 mg/dLNormalS
1979-09-08Cholesterol in HDL [Mass/volume] in Serum or Plasma46mg/dL>=40 mg/dLNormalS
1979-09-08Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation86mg/dL<=99 mg/dLNormalS
1979-09-08Triglyceride [Mass/volume] in Serum or Plasma130mg/dL<=149 mg/dLNormalS
1979-10-06Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1979-10-06Total score [Mini-Cog]5{score}S
1979-10-27Six minute walk test425mPredicted about 520 m for his age, sex and height; lower limit about 400 mNormalS
1979-10-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
1979-07-14Body height191cmS
1979-07-14Body weight82.6kgS
1979-07-14Body mass index (BMI) [Ratio]22.6kg/m2S
1979-07-14Systolic blood pressure136mm[Hg]S
1979-07-14Diastolic blood pressure82mm[Hg]S
1979-07-14Heart rate84/minS
1979-07-14Respiratory rate18/minS
1979-07-14Body temperature36.7CelS
1979-07-14Oxygen saturation in Arterial blood by Pulse oximetry94%S
1979-07-28Body height191cmS
1979-07-28Body weight82.4kgS
1979-07-28Body mass index (BMI) [Ratio]22.6kg/m2S
1979-07-28Systolic blood pressure132mm[Hg]S
1979-07-28Diastolic blood pressure80mm[Hg]S
1979-07-28Heart rate82/minS
1979-07-28Respiratory rate18/minS
1979-07-28Body temperature36.6CelS
1979-07-28Oxygen saturation in Arterial blood by Pulse oximetry94%S
1979-09-08Body height191cmS
1979-09-08Body weight82.8kgS
1979-09-08Body mass index (BMI) [Ratio]22.7kg/m2S
1979-09-08Systolic blood pressure130mm[Hg]S
1979-09-08Diastolic blood pressure78mm[Hg]S
1979-09-08Heart rate78/minS
1979-09-08Respiratory rate16/minS
1979-09-08Body temperature36.6CelS
1979-09-08Oxygen saturation in Arterial blood by Pulse oximetry95%S
1979-10-27Body height191cmS
1979-10-27Body weight83.4kgS
1979-10-27Body mass index (BMI) [Ratio]22.9kg/m2S
1979-10-27Systolic blood pressure128mm[Hg]S
1979-10-27Diastolic blood pressure78mm[Hg]S
1979-10-27Heart rate76/minS
1979-10-27Respiratory rate16/minS
1979-10-27Body temperature36.6CelS
1979-10-27Oxygen saturation in Arterial blood by Pulse oximetry95%S
1979-10-06Body height191cmS
1979-10-06Body weight83kgS
1979-10-06Body mass index (BMI) [Ratio]22.8kg/m2S
1979-10-06Systolic blood pressure128mm[Hg]S
1979-10-06Diastolic blood pressure76mm[Hg]S
1979-10-06Heart rate76/minS
1979-10-06Respiratory rate16/minS
1979-10-06Body temperature36.6CelS
1979-10-06Oxygen saturation in Arterial blood by Pulse oximetry95%S
1979-09-22Body height191cmS
1979-09-22Body weight82.2kgS
1979-09-22Body mass index (BMI) [Ratio]22.5kg/m2S
1979-09-22Systolic blood pressure134mm[Hg]S
1979-09-22Diastolic blood pressure80mm[Hg]S
1979-09-22Heart rate96/minS
1979-09-22Respiratory rate22/minS
1979-09-22Body temperature37.5CelS
1979-09-22Oxygen saturation in Arterial blood by Pulse oximetry92%S

Encounters

DatePurposeStatusProvenance
1979-07-14Establishing primary care for two years of breathlessness on exertion and a morning cough: history, examination, blood tests including alpha-1 antitrypsin and eosinophils, ECG, NT-proBNP, cardiovascular risk, vaccines, a reliever inhaler and a pulmonology consultationfinishedS
1979-07-28Two-week review on the day of the pulmonology consultation: spirometry with race-neutral interpretation, blood gas, six-minute walk, GOLD group and first maintenance inhaler, inhaler technique, pulmonary rehabilitation and lung cancer screeningfinishedS
1979-09-08Eight-week review: symptoms on the new inhaler, technique, rehabilitation, the screening CT and the lipid responsefinishedS
1979-10-27Fifteen-week review after an exacerbation and pulmonary rehabilitation: symptoms, exacerbation history, GOLD group, oxygen, the action plan and the plan aheadfinishedS
1979-09-22Same-day sick visit for a COPD exacerbationfinishedS
1979-10-06Subsequent annual wellness visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Breathlessness work-up at intake: symptoms with the CAT and mMRC, exacerbation history over the past year, smoking history and examination; blood count with eosinophils, alpha-1 antitrypsin once, kidney function, HbA1c, lipids, NT-proBNP and a 12-lead ECG; resting oxygen saturation read with care in darker skincompletedGL-GOLD-2025, GL-CMID-2026, GL-ATS-RACE-2023S
Pulmonology consultation to confirm the diagnosis with spirometry, interpret it with race-neutral equations, and advise on treatment, oxygen and rehabilitationcompletedGL-GOLD-2025, GL-ATS-RACE-2023S
Albuterol with a spacer as needed for breathlessness, with technique checked at the visitcompletedGL-GOLD-2025S
Maintenance therapy for GOLD group B: a LAMA with a LABA (umeclidinium with vilanterol) once daily; no inhaled corticosteroid with eosinophils below 0.10 x 10^3/uL and no exacerbations; inhaler technique and inspiratory effort checked at every visit; treatment reviewed at each follow-up for symptoms and exacerbationscompletedGL-GOLD-2025, GL-CMID-2026S
Pulmonary rehabilitation: twice a week for about ten weeks, with six-minute walks at entry and exit, then a home exercise programcompletedGL-ATS-PR-2023, GL-CMID-2026S
Oxygen: room-air arterial blood gas and six-minute walk oximetry; long-term oxygen only if resting PaO2 is 55 mm Hg or less (60 with cor pulmonale or polycythemia), confirmed twice; no long-term or ambulatory oxygen for moderate desaturationcompletedGL-ATS-LTOT-2020, GL-LOTT-2016, GL-SJODING-2020S
Lung cancer screening: yearly low-dose CT at 50 to 80 with 20 or more pack-years, after shared decision-making, while he has quit within fifteen years and remains fit for treatmentcompletedGL-USPSTF-LUNG-2021, GL-CMID-2026S
Cardiovascular risk: moderate-intensity atorvastatin by shared decision, with a lipid panel at about eight weeks; blood pressure at each visit; ECG reviewed after any exacerbationcompletedGL-USPSTF-STATIN-2022, GL-GOLD-2025S
Vaccines: PCV20 and Tdap now; influenza, RSV and COVID-19 in the autumn; recombinant zostercompletedGL-CDC-IMZ-2026, GL-GOLD-2025S
COPD action plan, spoken and written: what to do on a good day, when symptoms worsen (reliever, call the clinic the same day), and when to call 911; staying smoke-freecompletedGL-GOLD-2025S

Goals

GoalTargetStatusOutcomeProvenance
Find the cause of the breathlessness1979-07-28completedCOPD confirmed by spirometry (post-bronchodilator FEV1/FVC 0.58); heart failure unlikely (NT-proBNP 92, normal ECG); alpha-1 antitrypsin normalS
Walk farther with less breathlessness1979-10-27completedSix-minute walk 360 to 425 m after rehabilitation; CAT 18 to 11S
Fewer and milder flare-ups, treated early1980-07-14activeOne moderate exacerbation treated at home within a day of starting, using the action plan; no hospital stayS
LDL below 100 mg/dL1979-09-08completedLDL 148 to 86 mg/dL on atorvastatin 20 mgS
Vaccines up to date1979-10-06completedPCV20 and Tdap at intake; influenza, RSV, COVID-19 and the first zoster dose at the wellness visitS

Functional Status

Mental Status